• Profile
Close

Effects of soy isoflavones on serum lipids and lipoprotein (a) in peritoneal dialysis patients

Nutrition, Metabolism & Cardiovascular Diseases May 09, 2020

Yari Z, Tabibi H, Najafi I, et al. - Researchers performed this randomized, double-blind, placebo-controlled trial to determine how soy isoflavone supplementation influences serum lipids and lipoprotein (a) [Lp(a)] in peritoneal dialysis (PD) patients. They randomized 40 PD patients to either the isoflavone or the placebo group. They administered 100 mg soy isoflavone daily for 8 weeks in the patients in the isoflavone group, and corresponding placebos in the placebo group. From each patient, experts collected 7 mL of blood at baseline and the end of the 8th week to measure serum triglycerides, total cholesterol, LDL-C, HDL-C, and Lp(a). According to the findings, a decrease in serum Lp(a) and a rise in HDL-C level—the two determinants of cardiovascular disease in PD patients—was brought about by daily administration of 100 mg soy isoflavones.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay